Paclitaxel, topotecan and rituximab: Long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma

Jason R. Westin, Peter Mclaughlin, Jorge Romaguera, Fredrick B. Hagemeister, Barbara Pro, Nam H. Dang, Felipe Samaniego, Maria A. Rodriguez, Luis Fayad, Yasuhiro Oki, Michelle Fanale, Nathan Fowler, Loretta Nastoupil, Lei Feng, Evelyn Loyer, Anas Younes

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Paclitaxel, topotecan and rituximab: Long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences